Brendan M. Weiss
0000-0002-4448-3855
Publication & Citation Trends
Publications
0 total
Feasibility of Decentralized Real-World Monitoring of SARS-CoV-2 Booster Vaccines and COVID-19 Outcomes in Myeloma.
Cited by 0
Semantic Scholar
Preclinical Proof-of-Concept of an mRNA-Based T Cell Engager Targeting BCMA, FcRH5, and GPRC5D for the Treatment of Multiple Myeloma
Cited by 1
Semantic Scholar
Initial Results from the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections
Cited by 1
Semantic Scholar
Feasibility and Implementation of the ASH Research Collaborative's COVID-19 Outcomes in Myeloma and the Impact of Vaccines (COSMIC): A Decentralized, Real-World Evidence Study for Patients with Multiple Myeloma to Monitor Outcomes Related to COVID-19 Vaccines and Infections
Cited by 1
Semantic Scholar
Strategies for successful dose optimization in oncology drug development: a practical guide
Cited by 2
Semantic Scholar
Preclinical Proof-of-Concept of a Novel mRNA-Based Therapeutic Combination of an FcRH5 Targeted NK Cell Engager and an IL-15 Superagonist for the Treatment of Multiple Myeloma
Cited by 0
Semantic Scholar
SOLVING CLINICAL PROBLEMS IN BLOOD DISEASES
Cited by 14
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(102)
Amyloidosis: Diagnosis, Treatment, Outcomes
(56)
CAR-T cell therapy research
(29)
Immunotherapy and Immune Responses
(27)
Chronic Lymphocytic Leukemia Research
(21)
Affiliations
Goethe University Frankfurt
University of Maryland, Baltimore
MedStar Washington Hospital Center
San Antonio Military Medical Center
National Institutes of Health